amfAR, The Foundation for AIDS Research

Collaborating for a Cure 

Arche image

Launched in 2010, the amfAR Research Consortium on HIV Eradication, or ARCHE, supports collaborative teams of scientists in the U.S. and around the world working on a range of HIV cure strategies. To date, amfAR has awarded 53 ARCHE grants, totaling close to $15 million.

“We’ve seen great strides in our collective understanding 
of how HIV could potentially be eradicated.”
—amfAR CEO Kevin Robert Frost.

 "amfAR has a long and successful history of bringing people together to take on the big challenges of HIV/AIDS," says Dr. Rowena Johnston, amfAR’s vice president and director of research. "We’re tremendously excited by this consortium. And we’re confident that this collaborative approach will create a synergy that produces results that exceed what can be generated in individual laboratories."  

ARCHE Group 1
amfAR Vice President and Director of Research Dr. Rowena Johnston (fourth from left) with several recent ARCHE grantees.

ARCHE Grantees

2017:
New amfAR Research Grants Advance Gene Therapy and Other Innovative Approaches to HIV Cure

2016:
New amfAR Grant Addresses Key Challenge in Cure Research

2015:
New amfAR Awards Accelerate Research Towards HIV Cure

2014:
Pursuit of HIV Cure Gets Funding Boost from amfAR

HIV Cure Research Gains Momentum from New amfAR Funding

2013:
Infusion of Funding for amfAR HIV Cure Consortium

2012:
Entering Third Year, amfAR Consortium Gathers Momentum in Quest for HIV/AIDS Cure

amfAR Announces Second Round of Cure-Focused Research Grants in Third Year

2011:
amfAR Consortium Helps Lead Efforts for HIV/AIDS Cure

2010:
ARCHE Research Teams and Their Projects

  ARCHE Group 2
ARCHE grantees meet at the amfAR office to discuss their research.  

ARCHE News and Features 

Using Groundbreaking CAR-T Cancer Therapy to Eliminate HIV

A Gene Therapy Revolution?

Stabilize or Stimulate? A New Approach to Attacking the HIV Reservoir

One Cure May Not Fit All

Harnessing the Power of Antibodies

Boosting Killer T cells to Eliminate HIV Reservoirs

Sizing Up the HIV Reservoir

Surprising New Development in "Mississippi Child" Case

Testing “Shock and Kill”

New Clues to the Nature of HIV Reservoirs

Working Towards a Cure

Researcher Reports Two HIV Patients Showing No Signs of Virus in Wake of Stem-Cell Transplants

Perfecting Tools to Monitor HIV Viral Loads

Keeping Track of HIV Reservoirs

Research Support from amfAR Documents First Case of Child Cured of HIV

amfAR Awards Three New ARCHE Grants for Cure Research

A Cure for HIV/AIDS: Recent Breakthroughs and New Research Frontiers

Defining HIV Reservoirs

Leading the Charge in Cure Research

HIV in the Crosshairs

Destroying HIV Reservoirs

As Cure Search Intensifies, Questions Arise

Gene Therapy and the Potential for an HIV Cure

amfAR Symposium Looks to Holy Grail of AIDS Research 

amfAR Ramps Up Investment in HIV Cure Research 

ARCHE Researchers Prove the Value of Collaboration 

The Search for a Cure—Why Now? 

Charting a Path to a Cure 

amfAR Consortium To Speed Search for HIV/AIDS Cure 

The Search for a Cure: An Enduring Commitment 

amfAR Launches Cure Consortium